- Home
- KRG vs OPCH Comparison
KRG vs OPCH Comparison
Compare KRG & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$25.74
HOLD
Current Price
$29.90
Company Overview
Basic Information| Metric | KRG | OPCH |
|---|---|---|
| Founded | 1971 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Nursing Services |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.9B |
| IPO Year | 2004 | 1996 |
Fundamental Metrics
Financial Performance| Metric | KRG | OPCH |
|---|---|---|
| Price | $25.74 | $29.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | $25.60 | ★ $37.44 |
| AVG Volume (30 Days) | 1.8M | ★ 1.9M |
| Earning Date | 05-20-2026 | 05-22-2026 |
| Dividend Yield | ★ 4.50% | N/A |
| EPS Growth | ★ 6750.00 | 3.25 |
| EPS | ★ 1.37 | 1.27 |
| Revenue | $844,365,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | N/A | $7.53 |
| Revenue Next Year | $3.27 | $8.58 |
| P/E Ratio | ★ $18.80 | $23.50 |
| Revenue Growth | 0.30 | ★ 16.17 |
| 52 Week Low | $18.52 | $24.24 |
| 52 Week High | $26.38 | $36.80 |
Technical Indicators
Market Signals| Indicator | KRG | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 59.12 | 29.16 |
| Support Level | $21.95 | $29.23 |
| Resistance Level | N/A | $31.14 |
| Average True Range (ATR) | 0.47 | 1.25 |
| MACD | -0.06 | -0.54 |
| Stochastic Oscillator | 54.35 | 9.49 |
Price Performance
Historical Comparison KRG
OPCH
About KRG Kite Realty Group Trust
Kite Realty Group Trust specializes in owning, operating, acquiring, developing, and redeveloping high-quality open-air shopping centers and mixed-use assets. The company generates the majority of its revenue from contractual rents and reimbursement payments received from tenants.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.